PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
|Articles|May 2, 2020
- Pharmaceutical Technology-05-02-2020
- Volume 44
- Issue 5
Small-Volume Conversion Kit for Bathless Dissolution Testers
Distek’s small-volume conversion kit for its Model 2500 Select bathless dissolution tester uses bathless heating technology and the continuous monitoring and control of the in-vessel temperature to eliminate the water bath in the dissolution tester.
Distek’s small-volume conversion kit for its Model 2500 Select bathless dissolution tester uses bathless heating technology and the continuous monitoring and control of the in-vessel temperature to eliminate the water bath in the dissolution tester. With the ability to run lower volumes ranging from 30–100 mL, formulators can perform rapid dissolution or solubility evaluations using less API. The kit can also be used with manual or semi-automated sampling techniques as well as in-situ UV fiber optics.
Articles in this issue
over 6 years ago
Modern Drug Manufacturing Key to COVID-19 Responseover 6 years ago
How Fast Is Too Fast?over 6 years ago
Starting a Career in the Bio/Pharmaceutical Industryover 6 years ago
Can We Teach an Old Drug New Tricks?over 6 years ago
Good Manufacturing Practices: Aseptic and Sterile Processingover 6 years ago
Inline High Shear Mixersover 6 years ago
Pre-Packed Columnsover 6 years ago
Laser-Marked Smart ContainersRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.